Pharmaguy's Insights Into Drug Industry News
189.8K views | +27 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

@Richmeyer Rips Facebook a New One for Hosting Anti-Xarelto "Ambulance Chaser" Ads

@Richmeyer Rips Facebook a New One for Hosting Anti-Xarelto "Ambulance Chaser" Ads | Pharmaguy's Insights Into Drug Industry News | Scoop.it

According to the Times “If I were a Facebook executive, I might feel a Frankensteinian sense of unease these days. The company has been hit with a series of scandals that have bruised its image, enraged its critics and opened up the possibility that in its quest for global dominance, Facebook may have created something it can’t fully control.”  And they want pharma to advertise more?

As CEO of Facebook Mr. Zuckerberg’s modus operandi as a leader is to fix things long after they have broken , rather than to prevent problems in the first place.  For pharma that’s a major issue.

This is an ad that I keep seeing on Facebook as I was doing some research for a client.  I did an analysis of the comments and 85% were negative.  If I was a DTC manager or media buyer I would not proceed to give more money to the this monster.

Facebook has become some huge and profitable that they feel they can do no wrong.  They don’t have enough people with industry experience and their continued efforts to court pharma ad dollars is almost insulting.

Obviously Xarelto has risks, like any prescription drug, but hosting ads for ambulance chasers who profit off patient woes is is not a platform I would ever recommend to clients.

Pharma Guy's insight:

Still , this is less of a problem for me than hosting fake news ads/stories from Russian agents!

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

What's BMS Doing on Facebook?

What's BMS Doing on Facebook? | Pharmaguy's Insights Into Drug Industry News | Scoop.it

The BMS corporate Facebook page features its collaborations to develop new cancer therapies, but it's low man on the totem pole in terms of "likes."

 

Read more about this here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Great DTC Commercial for Anti-Depressant Rexulti, But Depressing Facebook Presence!

Great DTC Commercial for Anti-Depressant Rexulti, But Depressing Facebook Presence! | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Great DTC Ad for Anti-Deprtessant Rexulti, But Depressing Facebook Presense!

 

The US market for major depressive disorders will rise from $2.4 billion in 2015 to $4.6 billion in 2025. Rexulti, I [Rich Meyer] believe, is doing a great job trying to reach new patients with a great creative TV spot.

 

When visiting Rexulti.com, the first message you see is “still struggling with depression, even on an antidepressant?” It ties in very nicely with the TV commercial showing people turning away from everyday situations while holding up a face with a smile on it. I believe the creative is hard hitting and targeted.

 

 

The website completes the creative with full integration and a host of helpful patient tools, but wouldn’t it be great to hear and see actual patient stories or patients talking about their battle with depression?

 

It seems that Rexulti is getting ready to take a huge slice out of the depression market, but they really need to take the next step and bring patients together to talk about depression.

 

On Facebook a search for Rexulti only results in class action lawsuit pages.

 

This of course is going to scare the hell out of potential patients and it’s something this brand can’t ignore of they really believe in their product.

Pharma Guy's insight:

Love the tiny notice: "Actor portrayal"!

more...
No comment yet.